[Attempt at preventing the hemolytic action of primaquine in persons with a gluose-6-phosphate dehydrogenase activity deficit in the erythrocytes by the simultaneous administration of xylitol and riboflavin].
D000293:Adolescent; D000328:Adult; D001382:Azerbaijan; D002648:Child; D004359:Drug Therapy, Combination; D004912:Erythrocytes / Q000201:enzymology*; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000188:drug therapy*; D006801:Humans; D008288:Malaria / Q000188:drug therapy; D011319:Primaquine / Q000627:therapeutic use*; D012256:Riboflavin / Q000627:therapeutic use*; D014993:Xylitol / Q000627:therapeutic use*
D011319:Primaquine; D012256:Riboflavin; D014993:Xylitol
Popytka preduprezhdeniia gemoliticheskogo deĭstviia primakhina u liudeĭ s defitsitom aktivnosti gliukozo-6-fisfatdegudrogenazy v éritritsitakh odnovremennym vvedeniem ksilita i riboflavina.